Cathay Financial Holding Co. Ltd. logo

Cathay Financial Holding Co. Ltd. (067080)

Market Closed
22 Oct, 05:30 AM
TWSE TWSE
NT$
0. 76
-0.12
-13.6364%
NT$
- Market Cap
- P/E Ratio
200% Div Yield
804,000 Volume
- Eps
NT$ 0.88
Previous Close
Add Transaction
Day Range
0.76 0.94
Year Range
0.72 4.12
Want to track 067080 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

067080 closed Thursday lower at NT$0.76, a decrease of -13.6364% from Wednesday's close, completing a monthly decrease of -50.6494% or -NT$0.78. Over the past 12 months, 067080 stock lost -76.6871%.
067080 pays dividends to its shareholders, with the most recent payment made on Jan 05, 2026.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).

067080 Chart

Cathay Financial Holding Co. Ltd. (067080) FAQ

What is the stock price today?

The current price is NT$0.76.

On which exchange is it traded?

Cathay Financial Holding Co. Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 067080.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 200%.

What is its market cap?

As of today, no market cap data is available.

Has Cathay Financial Holding Co. Ltd. ever had a stock split?

No, there has never been a stock split.

Cathay Financial Holding Co. Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Kim Eun-Seok CEO
TWSE Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

DAE HWA Pharmaceutical Co., Ltd., established in 1984, is a prominent pharmaceutical company based in Seoul, South Korea. With a focus on innovation and quality, the company specializes in the production and supply of a wide array of pharmaceutical products catering to various therapeutic areas. DAE HWA Pharmaceutical is dedicated to improving healthcare outcomes for patients through its extensive portfolio of medications and advanced drug delivery systems. The company’s commitment to R&D and global health has enabled it to expand its market presence to approximately 22 countries across Asia, South America, the Middle East, and Africa. Through persistent efforts in innovation and expansion, DAE HWA strives to meet the diverse healthcare needs of communities worldwide.

Products and Services

DAE HWA Pharmaceutical Co., Ltd. offers a comprehensive range of pharmaceutical products and services, including:

  • Anticancer: Providing treatments targeting various types of cancer, focusing on improving patient outcomes and quality of life.
  • Antibiotics and Antifungal: Wide range of antibiotics and antifungal medications for treating bacterial and fungal infections.
  • Antivirus and Anti-allergosis: Solutions for combating viral infections and managing allergies effectively.
  • Mental Health Treatments: Includes antidepressants, antiepileptics, and psychotropic agents for addressing various mental health conditions.
  • Chronic Disease Management: Medications for managing diabetes, hypertension, and hyperlipemia, essential for long-term health maintenance.
  • Pain Management: Analgesics, anti-inflammatory drugs, and skeletal muscle relaxants designed to alleviate pain and inflammation.
  • Osteoporosis and Arthritis: Treatments for bone diseases such as osteoporosis and arthritis, focusing on improving bone health and mobility.
  • Gastro-intestinal Disorders: A range of medications aimed at improving gastrointestinal health, including treatments for obesity and antispasmodics.
  • Transdermal Drug Delivery Systems: Innovative pharmaceutical preparations applied to the skin for systemic absorption, enhancing medication efficacy and patient convenience.
  • Active Pharmaceutical Ingredients (APIs): Supplying high-quality APIs for use in various pharmaceutical formulations.
  • Cosmetic and Skin Care: Products designed for cosmetic care, skin ailments, and nutritional support, enriching health and wellness.
  • Specialty Therapeutic Areas: Solutions for erectile dysfunction, urinary incontinence, prostatic hyperplasia, along with pregnancy support products.

These offerings underline DAE HWA Pharmaceutical’s dedication to advancing healthcare across multiple fronts, leveraging cutting-edge science and technology to deliver effective solutions.

Contact Information

Address: 2145, Nambusunhwan-ro
Phone: 82 2 6716 1071